How does Retatrutide work in your body?
Look at each hormone's job, then see why copying all three may change hunger, sugar in the blood, and the use of stored fuel.
What is the short answer to how retatrutide works?
Researchers made retatrutide, an unapproved drug, to copy three hormone messages. One comes from GLP-1, a gut hormone tied to hunger and blood sugar. This page explains each message and why the mix may matter.
GLP-1 can ease hunger and help control blood sugar. Glucagon may move stored fuel into use. In Phase 2, the mid-sized testing stage, the three-part mix brought more average weight loss than older drugs copying GLP-1 alone or GLP-1 with a second hormone in studies done so far.
The drug is a 39-amino-acid chain, meaning a chain of linked protein pieces. After a weekly shot, retatrutide reaches proteins on cells that receive all three hormone messages. The plain idea is that hunger may fall while your body draws more on stored fuel.
How does GLP-1 change hunger and insulin?
GLP-1 is a hormone your gut releases after you eat. When blood sugar rises, GLP-1 tells your body to release insulin. As sugar falls, that message fades, which lowers the chance of this hormone alone pushing sugar too low.
GLP-1 also slows food as it leaves your stomach. You may feel full sooner and have a smaller rise in blood sugar after a meal. This GLP-1 effect also reaches parts of the brain that guide hunger and fullness.
One review from 2025 looked at GLP-1, cravings, and reward in the brain [7]. In Phase 2 talks, 31 of 36 people taking retatrutide said hunger fell within the first 8 weeks [10]. Their reports fit the idea, but they don't prove which change in the body caused it.
What jobs do retatrutide's other two hormones have?
The other gut hormone is called GIP; your gut releases it near mealtime. GIP and GLP-1 both tell the pancreas to send out insulin after food. Close-up pictures showed retatrutide touching the cell protein that normally receives the GIP message [3].
Alongside GLP-1, GIP may also change how fat is stored or used. That could add to the fat loss caused by eating less. Human studies haven't proved how much this one hormone adds.
The pancreas makes glucagon, which can raise blood sugar when it falls too low. Retatrutide copies part of that message and may lead the body to use stored fuel. In the liver study, fat fell −82.4% with 12 mg after 24 weeks [5].
Too much glucagon could push blood sugar upward. The makers tried to keep some help with fuel use without a sharp rise. For you, that balance matters because it may shape both benefit and harm.
What can close-up cell pictures really tell you?
A 2024 lab study took close-up pictures of retatrutide touching proteins from cells [3]. Those proteins normally receive messages from GLP-1 and two other hormones. No person took part in the test.
The drug touched each protein in a somewhat different way. That finding helps explain how one medicine can carry three copied hormone messages. It doesn't show how strongly a whole person would respond.
The proteins appear on cells with different jobs, including cells tied to insulin, liver fat, hunger, and stomach movement. The pictures show contact, not the exact change inside each kind of cell. They can't predict your weight change or name the side effects you would face.
Why could three hormone messages change weight more?
Reviewers in 2025 focused on adults with obesity but without type 2 diabetes [9]. They asked why adding another gut hormone and glucagon to GLP-1 might lead to more weight loss. They used human studies and early lab work, so the answer remains an idea rather than final proof.
GLP-1 and the other gut hormone may help people eat less and handle blood sugar. Glucagon may draw more heavily on stored fuel. Those three effects could add together.
In Phase 2, the mid-sized test, average weight fell −24.2% with 12 mg over 48 weeks [1]. Another review from 2025 called the large Phase 2 finding a step beyond older GLP-1 drugs [6]. Larger Phase 3 studies must test whether the result holds in more people for longer. The study timeline shows when the changes appeared.